Publications by authors named "Constant Gillot"

Claim this Profile
N
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.
Constant Gillot, Clara David, Jean-Michel Dogné, Julien Cabo, Jonathan Douxfils

Clin Chem Lab Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study.
Marie Didembourg, Clara David, Laure Morimont, Eva Cransquint, Julien Favresse, Constant Gillot

Heliyon· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population.
Constant Gillot, Jean-Louis Bayart, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils

Case Rep Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?
Julien Favresse, Marie Tré-Hardy, Constant Gillot, Roberto Cupaiolo, Alain Wilmet

Heliyon· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
Constant Gillot, Marie Tré-Hardy, Roberto Cupaiolo, Laurent Blairon, Alain Wilmet

Virology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.
Julien Favresse, Constant Gillot, Julien Cabo, Clara David, Jean-Michel Dogné

Int J Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
Julien Favresse, Constant Gillot, Mélanie Closset, Julien Cabo, Loris Wauthier

J Med Virol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
Germain Simon, Julien Favresse, Constant Gillot, Mélanie Closset, Émilie Catry

Clin Chem Lab Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing.
Constant Gillot, Jean-Louis Bayart, Mélanie Closset, Julien Cabo, Vincent Maloteau

Clin Chem Lab Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals.
Jean-Louis Bayart, Constant Gillot, Jean-Michel Dogné, Gatien Roussel, Valérie Verbelen

J Clin Virol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.
Julien Favresse, Constant Gillot, Jean-Louis Bayart, Clara David, Germain Simon

J Med Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.
Constant Gillot, Julien Favresse, Vincent Maloteau, Valérie Mathieux, Jean-Michel Dogné

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.
Emilie Catry, Julien Favresse, Constant Gillot, Jean-Louis Bayart, Damien Frérotte

Viruses· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.
Laure Morimont, Mélanie Dechamps, Clara David, Céline Bouvy, Constant Gillot

Biomolecules· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity.
Julien Favresse, Jean-Louis Bayart, Clara David, Constant Gillot, Grégoire Wieërs

Viruses· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment.
Julien Favresse, Jean-Louis Bayart, Clara David, Marie Didembourg, Constant Gillot

Clin Chem Lab Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells.
Constant Gillot, Julien Favresse, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils

Bio Protoc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant.
Jean-Louis Bayart, Jonathan Degosserie, Julien Favresse, Constant Gillot, Marie Didembourg

Viruses· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.
Constant Gillot, Julien Favresse, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils

Viruses· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
Jonathan Douxfils, Constant Gillot, François Mullier, Julien Favresse

J Infect· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers.
Jean-Louis Bayart, Jonathan Douxfils, Constant Gillot, Clara David, François Mullier

Vaccines (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.
Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean-Michel Dogné

Front Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature.
Jonathan Douxfils, Constant Gillot, Émilie De Gottal, Stéphanie Vandervinne, Jean-Louis Bayart

Vaccines (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Schulte-Pelkum, J. Comment on "Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. 2021, , 556".
Julien Favresse, Constant Gillot, Jonathan Douxfils

Microorganisms· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.
Julien Favresse, Constant Gillot, Laura Di Chiaro, Christine Eucher, Marc Elsen

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis